343 related articles for article (PubMed ID: 24050623)
1. Sjögren's syndrome.
Mavragani CP; Moutsopoulos HM
Annu Rev Pathol; 2014; 9():273-85. PubMed ID: 24050623
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms and New Strategies for Primary Sjögren's Syndrome.
Mavragani CP
Annu Rev Med; 2017 Jan; 68():331-343. PubMed ID: 28099084
[TBL] [Abstract][Full Text] [Related]
3. B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF.
Varin MM; Le Pottier L; Youinou P; Saulep D; Mackay F; Pers JO
Autoimmun Rev; 2010 Jul; 9(9):604-8. PubMed ID: 20457281
[TBL] [Abstract][Full Text] [Related]
4. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
[TBL] [Abstract][Full Text] [Related]
5. The geoepidemiology of Sjögren's syndrome.
Mavragani CP; Moutsopoulos HM
Autoimmun Rev; 2010 Mar; 9(5):A305-10. PubMed ID: 19903539
[TBL] [Abstract][Full Text] [Related]
6. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome.
Matsumoto I; Tsubota K; Satake Y; Kita Y; Matsumura R; Murata H; Namekawa T; Nishioka K; Iwamoto I; Saitoh Y; Sumida T
J Clin Invest; 1996 Apr; 97(8):1969-77. PubMed ID: 8621782
[TBL] [Abstract][Full Text] [Related]
7. Sjögren's syndrome: immunobiology of exocrine gland dysfunction.
Fox RI
Adv Dent Res; 1996 Apr; 10(1):35-40. PubMed ID: 8934921
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren's syndrome.
Nakamura H; Kawakami A; Eguchi K
Transl Res; 2006 Dec; 148(6):281-8. PubMed ID: 17162248
[TBL] [Abstract][Full Text] [Related]
9. Novel autoantibodies in Sjögren's syndrome: A comprehensive review.
Martín-Nares E; Hernández-Molina G
Autoimmun Rev; 2019 Feb; 18(2):192-198. PubMed ID: 30572138
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune Epithelitis and Chronic Inflammation in Sjögren's Syndrome-Related Dry Eye Disease.
Ogawa Y; Takeuchi T; Tsubota K
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769250
[TBL] [Abstract][Full Text] [Related]
11. Sjögren's syndrome--a plethora of clinical and immunological phenotypes with a complex genetic background.
Jonsson R; Bolstad AI; Brokstad KA; Brun JG
Ann N Y Acad Sci; 2007 Jun; 1108():433-47. PubMed ID: 17894008
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of Sjögren's syndrome: what we know and what we should learn.
Tzioufas AG; Kapsogeorgou EK; Moutsopoulos HM
J Autoimmun; 2012 Aug; 39(1-2):4-8. PubMed ID: 22326205
[TBL] [Abstract][Full Text] [Related]
13. Sjögren's syndrome and hepatitis C virus.
Ramos-Casals M; García-Carrasco M; Cervera R; Font J
Clin Rheumatol; 1999; 18(2):93-100. PubMed ID: 10357112
[TBL] [Abstract][Full Text] [Related]
14. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
15. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.
Ushio A; Arakaki R; Eguchi H; Hotta F; Yamada A; Kudo Y; Ishimaru N
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587293
[TBL] [Abstract][Full Text] [Related]
16. Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors.
Christodoulou MI; Kapsogeorgou EK; Moutsopoulos NM; Moutsopoulos HM
Am J Pathol; 2008 Nov; 173(5):1389-96. PubMed ID: 18818377
[TBL] [Abstract][Full Text] [Related]
17. Histopathological changes in exocrine glands of murine transplantation chimeras. I: The development of Sjögren's syndrome-like changes secondary to GVH induced lupus syndrome.
Sørensen I; Ussing AP; Prause JU; Blom J; Larsen S; Spärck JV
Autoimmunity; 1992; 11(4):261-71. PubMed ID: 1581471
[TBL] [Abstract][Full Text] [Related]
18. EBV and other viruses as triggers of tertiary lymphoid structures in primary Sjögren's syndrome.
Lucchesi D; Pitzalis C; Bombardieri M
Expert Rev Clin Immunol; 2014 Apr; 10(4):445-55. PubMed ID: 24564506
[TBL] [Abstract][Full Text] [Related]
19. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice.
Haneji N; Hamano H; Yanagi K; Hayashi Y
J Immunol; 1994 Sep; 153(6):2769-77. PubMed ID: 8077681
[TBL] [Abstract][Full Text] [Related]
20. Secondary tumours in Sjögren's syndrome.
Kovács L; Szodoray P; Kiss E
Autoimmun Rev; 2010 Feb; 9(4):203-6. PubMed ID: 19602455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
